<DOC>
	<DOC>NCT00705224</DOC>
	<brief_summary>Naïve patients with chronic hepatitis C (CHC) of any genotype will be treated with a standard treatment regimen (pegylated interferon and ribavirin) according to routine clinical practice in Russia. The objective of this study is to examine the influence of insulin resistance on the safety and efficacy of treatment with pegylated interferon and ribavirin and to determine the prevalence of insulin resistance in different populations of CHC patients.</brief_summary>
	<brief_title>Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562)</brief_title>
	<detailed_description>consecutive patient sampling</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>Confirmed diagnosis of CHC according to local regulations Naïve Pegylated Interferon (PEGIFN) CHC patient No contraindications for PEGIFN CHC therapy Negative urine pregnancy test result (for females of childbearing potential) documented within the 24hour period prior to the first dose of study drugs. Additionally, all female patients of childbearing potential and all males with female partners of childbearing potential must use two forms of effective contraception (combined) during treatment and 6 months after treatment end Willingness to give written informed consent and willingness to participate in and comply with the study requirements. PEGIFN treatment in history Contraindications for PEGIFN CHC therapy Females who are pregnant or breastfeeding Male partners of females who are pregnant Potentially unreliable participants, and those judged by the investigator to be unsuitable for the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>